Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-31
2005-05-31
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S292000, C514S275000, C514S258100, C514S252040, C546S082000, C544S238000, C544S331000, C544S333000
Reexamination Certificate
active
06900223
ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the immunotherapeutic treatment of transplant rejection, autoimmune disease or graft vs. host disease.
REFERENCES:
patent: 3669950 (1972-06-01), Hoehn et al.
patent: 3787430 (1974-01-01), Hoehn
patent: 4560689 (1985-12-01), Yokoyama
patent: 4814450 (1989-03-01), Yokoyama
patent: 6121257 (2000-09-01), Kawai et al.
patent: 6635633 (2003-10-01), Cai et al.
Ian T. Forbes et al., Journal of Medicinal Chemistry, 1990, vol. 33, 2640-2645.
Erbe, D. V.; Wang, S.; Xing, Y.; and Tobin, J. F.; The Journal of Biological Chemistry (2002), vol. 277, 7363-7368.
Chen Lihren
Davies Audrey Molina
Green Neal Jeffrey
Stack Gary Paul
Tam Steve Yikkai
Huang Evelyn Mei
Lences Barbara L.
Wyeth
LandOfFree
Dihydrodipyrazolopyridinone inhibitors of B7-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydrodipyrazolopyridinone inhibitors of B7-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydrodipyrazolopyridinone inhibitors of B7-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3379564